Viewing Study NCT04532918


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-02-28 @ 8:32 PM
Study NCT ID: NCT04532918
Status: COMPLETED
Last Update Posted: 2023-03-27
First Post: 2020-08-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: D5495C00013
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View